سرايا الإخبارية
سرايا الإخبارية
Ready to play
Ready to play
A U.S. study found that the "Mangar" injection reduces the risk of heart attacks by 33% compared to other medications used to treat type 2 diabetes. The study followed approximately 53,000 patients with diabetes and heart disease and discovered that using "Mangar" significantly lowered the rates of serious cardiac events, including heart attacks and strokes, as well as reducing deaths and hospitalizations due to infections. The researchers emphasized that these findings suggest "Mangar" may offer cardiovascular benefits similar to those proven with "Semaglutide." The results indicate that using "Mangar" alongside primary treatment could help in preventing heart problems. It is also now being used to promote weight loss in individuals with medical conditions related to weight.
Notice: This Is an AI-Generated Summary
Comments (0)